Profiling Urticaria for the Identification of Subtypes
NCT01637116 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 195
Last updated 2015-07-28
Summary
The primary purpose of this study is to identify and characterize novel diagnostic markers for autoimmune urticaria, a subset of chronic spontaneous urticaria.
Additional aims: include the comparison of the clinical profiles of autoreactive, autoimmune and non autoreactive / autoimmune urticaria and the quality of life impairment in these subsets of chronic spontaneous urticaria.
Conditions
- Non-autoreactive Chronic Spontaneous Urticaria
- Autoimmune Chronic Spontaneous Urticaria
- Autoreactive, Non-autoimmune Chronic Spontaneous Urticaria
Sponsors & Collaborators
-
Marcus Maurer
lead OTHER
Principal Investigators
-
Marcus Maurer, Prof. Dr. med. · Charite-Universitätsmedizin Berlin
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- Germany
Study Locations
More Related Trials
-
Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)
NCT07166211 ·Status: RECRUITING ·Phase: PHASE2
-
Mepolizumab for the Treatment of Chronic Spontaneous Urticaria
NCT03494881 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria
NCT06795373 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients
NCT02329223 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment
NCT06228560 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria
NCT04513548 ·Status: TERMINATED ·Phase: PHASE1
-
Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody
NCT03183024 ·Status: COMPLETED ·Phase: PHASE4
-
Molecular Endotypes of Chronic Idiopathic Urticaria
NCT04774315 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Efficacy Study of Canakinumab to Treat Urticaria
NCT01635127 ·Status: UNKNOWN ·Phase: PHASE2
-
Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment
NCT01599637 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria
NCT07316114 ·Status: RECRUITING
-
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
NCT06865651 ·Status: RECRUITING ·Phase: PHASE2
-
Hydroxychloroquine Efficacy in Chronic Urticaria
NCT01073852 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
NCT07219615 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria
NCT06295302 ·Status: RECRUITING ·Phase: PHASE2
-
Interleukin-2 for Refractory Chronic Spontaneous Urticaria
NCT06924762 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria
NCT01713725 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria
NCT05936567 ·Status: COMPLETED ·Phase: PHASE2
-
Methotrexate in the Treatment of Chronic Idiopathic Urticaria
NCT01960283 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria
NCT02166151 ·Status: UNKNOWN ·Phase: PHASE3
-
Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients
NCT01803763 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Resistant Chronic Spontaneous Urticaria
NCT04827589 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
NCT06445023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria
NCT00189878 ·Status: TERMINATED ·Phase: PHASE2
-
STOP CSUA: phySical acTivity, mOod and sleeP in Chronic Spontaneous Urticaria and Angioedema
NCT05169645 ·Status: UNKNOWN